Remove 2014 Remove Compliance Remove DEA Remove Packaging
article thumbnail

Hemp CBD Across State Lines: North Carolina

Canna Law Blog

Currently, NCDA is operating under the 2014 Farm Bill, not the 2018 Farm Bill. The Commission believes this “narrow timeframe” is an “unnecessary obstacle for compliance.” NCDA would oversee good manufacturing practices for manufacturing, packaging, labeling, or holding operations for Hemp CBD.

Hemp 102
article thumbnail

Every Florida Medical Marijuana Law You Need to Know

CannaMD

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. SHORT ANSWER: Yes, but products must be contained in their original packaging. In-vehicle use is strictly prohibited.

Law 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

We believe there is a benefit to Delta-8 but there should be labeling or warnings on packages so that consumers are informed of potential minor intoxication effects. As a graduate student, he received the IPMI Richard Rubin Memorial Scholarship in 2014 for his research in precious metals.

article thumbnail

CBD Oracle Lab Study Shows Some Delta-8 Products Are 7700% Over the Legal Delta-9 THC Limit

Cannabis Law Report

Five of them used an age verification form , which is in compliance with the FDA age requirements and state laws, where the customer has to upload a photo of a government ID, and the other required a signature on delivery of the package. The second argument is based on a DEA interim final rule on the topic of synthetic THC.

THC 96
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

The AAFP advocates for robust regulation regarding labeling and child-proof packaging of all marijuana and cannabinoid products. Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process.